Correlation Between Recursion Pharmaceuticals and MORGAN

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and MORGAN at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and MORGAN into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and MORGAN STANLEY 395, you can compare the effects of market volatilities on Recursion Pharmaceuticals and MORGAN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of MORGAN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and MORGAN.

Diversification Opportunities for Recursion Pharmaceuticals and MORGAN

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Recursion and MORGAN is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and MORGAN STANLEY 395 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MORGAN STANLEY 5 and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with MORGAN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MORGAN STANLEY 5 has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and MORGAN go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and MORGAN

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 12.07 times more return on investment than MORGAN. However, Recursion Pharmaceuticals is 12.07 times more volatile than MORGAN STANLEY 395. It trades about 0.03 of its potential returns per unit of risk. MORGAN STANLEY 395 is currently generating about 0.02 per unit of risk. If you would invest  686.00  in Recursion Pharmaceuticals on September 14, 2024 and sell it today you would earn a total of  9.00  from holding Recursion Pharmaceuticals or generate 1.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy98.88%
ValuesDaily Returns

Recursion Pharmaceuticals  vs.  MORGAN STANLEY 395

 Performance 
       Timeline  
Recursion Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
MORGAN STANLEY 5 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MORGAN STANLEY 395 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, MORGAN is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Recursion Pharmaceuticals and MORGAN Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Recursion Pharmaceuticals and MORGAN

The main advantage of trading using opposite Recursion Pharmaceuticals and MORGAN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, MORGAN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MORGAN will offset losses from the drop in MORGAN's long position.
The idea behind Recursion Pharmaceuticals and MORGAN STANLEY 395 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation